Jesus Millan Nunez-Cortes
Overview
Explore the profile of Jesus Millan Nunez-Cortes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oblitas C, Demelo-Rodriguez P, Barrera-Lopez L, Galeano-Valle F, Rubio-Rivas M, Luque Del Pino J, et al.
Sci Rep
. 2025 Mar;
15(1):7722.
PMID: 40044746
This study aimed to assess the impact of SARS-CoV-2 therapies on the risk of venous thromboembolism (VTE) and other cardiovascular events. A retrospective, multicenter, observational study included hospitalized patients in...
2.
Oblitas C, Demelo-Rodriguez P, Alvarez-Sala-Walther L, Rubio-Rivas M, Navarro-Romero F, Giner Galvan V, et al.
Viruses
. 2024 Mar;
16(3).
PMID: 38543700
Background: This study aimed to validate the role of the D-dimer to lymphocyte ratio (DLR) for mortality prediction in a large national cohort of hospitalized coronavirus disease 2019 (COVID-19) patients....
3.
Pascual V, Diaz J, Millan Nunez-Cortes J, Perez-Martinez P
Clin Investig Arterioscler
. 2022 Nov;
35(3):155-163.
PMID: 36400610
The incorporation of a healthy diet, regular physical exercise and smoking cessation are the initial measures to reduce cardiovascular risk in patients with atherogenic dyslipidemia. In these patients, the nutritional...
4.
Klen R, Purohit D, Gomez-Huelgas R, Casas-Rojo J, Anton-Santos J, Millan Nunez-Cortes J, et al.
Elife
. 2022 May;
11.
PMID: 35579324
New SARS-CoV-2 variants, breakthrough infections, waning immunity, and sub-optimal vaccination rates account for surges of hospitalizations and deaths. There is an urgent need for clinically valuable and generalizable triage tools...
5.
Rubio-Rivas M, Mora-Lujan J, Formiga F, Arevalo-Canas C, Lebron Ramos J, Villalba Garcia M, et al.
J Gen Intern Med
. 2022 Apr;
37(8):1980-1987.
PMID: 35396659
Background: The WHO ordinal severity scale has been used to predict mortality and guide trials in COVID-19. However, it has its limitations. Objective: The present study aims to compare three...
6.
Olalla-Sierra J, Martin-Escalante M, Garcia-Alegria J, Rubio-Rivas M, de Miguel-Campo B, Zurita-Etayo M, et al.
AIDS
. 2022 Mar;
36(5):683-690.
PMID: 35323157
Objective: To compare coronavirus disease 2019 (COVID-19) hospitalization outcomes between persons with and without HIV. Design: Retrospective observational cohort study in 150 hospitals in Spain. Methods: Patients admitted from 1...
7.
Lavilla Olleros C, Garcia C, Bendala Estrada A, Munoz A, Wikman Jogersen P, Fernandez Cruz A, et al.
PLoS One
. 2022 Jan;
17(1):e0261711.
PMID: 35061713
Objective: To describe the impact of different doses of corticosteroids on the evolution of patients with COVID-19 pneumonia, based on the potential benefit of the non-genomic mechanism of these drugs...
8.
Lavilla Olleros C, Lopez-Rubio M, Fanciulli C, Gonzalez-Munera A, Millan Nunez-Cortes J
Rev Fac Cien Med Univ Nac Cordoba
. 2021 Dec;
78(4):405-407.
PMID: 34962738
Introduction: Since the SARS-CoV-2 pandemics began, multiple cases of Guillain-Barre syndrome secondary to COVID-19 have been described. Its typical presentation consists of the triad of paresthesia, ascending muscle weakness and...
9.
Bendala Estrada A, Calderon Parra J, Fernandez Carracedo E, Muino Miguez A, Martinez A, Munez Rubio E, et al.
BMC Infect Dis
. 2021 Nov;
21(1):1144.
PMID: 34749645
Background: Since December 2019, the COVID-19 pandemic has changed the concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital due to...
10.
Rubio-Rivas M, Mora-Lujan J, Montero A, Aguilar Garcia J, Mendez Bailon M, Fernandez Cruz A, et al.
J Gen Intern Med
. 2021 Oct;
37(1):168-175.
PMID: 34664188
Background: The inflammatory cascade is the main cause of death in COVID-19 patients. Corticosteroids (CS) and tocilizumab (TCZ) are available to treat this escalation but which patients to administer it...